Health Insurance Subrogation vs. Pharmacy Liens: California PI Attorney Guide

James Wong — Founder & Pharmacist, LienScripts | July 19, 2024 | 8 min read

Subrogation claims and pharmacy liens are two entirely different animals — and confusing them at settlement can cost your client significantly. This guide explains the distinction, California's made-whole doctrine, ERISA considerations, and how proactive pharmacy lien enrollment can eliminate subrogation exposure on injury medications entirely.

Two Different Mechanisms — One Common Confusion

Pharmacy liens and health insurance subrogation both involve someone other than your client holding a financial interest in injury-related medications. But they arise from opposite directions, and the practical consequences at settlement are completely different.

Understanding the distinction is not just academic — it affects how you structure settlement negotiations, how you allocate proceeds, and how much of the recovery your client takes home.

[!KEY] Pharmacy liens eliminate subrogation exposure on injury medications entirely because the insurer never pays for lien-dispensed prescriptions — making proactive enrollment at intake the most effective subrogation risk mitigation available.

How Subrogation Works: The Reactive Model

When a health insurer pays for medical or pharmacy costs that arise from an injury caused by a third party, the insurer typically has a subrogation right — the right to be reimbursed from whatever the patient ultimately recovers in the personal injury case.

The key word is "paid." Subrogation only arises because the insurer already spent money on the patient's care. The insurer is essentially stepping into the patient's shoes and saying: "We covered your injury costs. Now that you've recovered from the responsible party, reimburse us."

Subrogation is reactive. The insurer pays first, then asserts a claim against the settlement second.

How Pharmacy Liens Work: The Proactive Model

A pharmacy lien operates on the opposite logic. When an injured patient enrolls in a pharmacy lien program at the beginning of their case, the lien provider agrees to dispense medications now and be repaid from the settlement later — without the patient paying out of pocket and without billing any health insurance at all.

Pharmacy lien medications are never submitted to health insurance. There is no claim, no payment from the insurer, and therefore no subrogation interest for the insurer to assert.

This is the most important practical distinction:

If the patient was on a pharmacy lien from the start, there is no subrogation claim on those medications — because the insurer never paid for them.

The Settlement Distribution Simplification

This matters enormously at settlement. When medications were handled through a pharmacy lien:

• The only lien on those medications is the pharmacy lien itself
• There is no health insurer asserting a competing subrogation claim on the same medications
• Settlement distribution on the pharmacy costs involves one party negotiation, not a three-way dispute between attorney, pharmacy lien provider, and health insurer

When medications were handled through health insurance (or in cases where the pharmacy lien wasn't set up and the client used insurance), you now have potential subrogation exposure on those costs — and depending on the insurer, that exposure can be significant.

California's Made-Whole Doctrine

California follows the made-whole doctrine for health insurance subrogation. Under this doctrine, a health insurer's subrogation claim is subordinated to the injured party's right to full recovery. Simply put:

• The insurer cannot recover its subrogation interest until the injured plaintiff has been fully compensated for all of their damages
• If the settlement is insufficient to make the plaintiff whole, the insurer receives nothing (or a reduced amount)

The made-whole doctrine is a powerful tool for California PI attorneys. However, applying it requires demonstrating that the total damages exceed the settlement — something that requires careful documentation of all injury-related losses.

[!NOTE] California's made-whole doctrine applies only to fully insured state-regulated plans — if your client's employer coverage is an ERISA self-funded plan, the doctrine does not apply and the insurer can enforce its reimbursement clause under federal law.

The common fund doctrine adds another layer: Under Sapiano v. Allstate and its progeny, a health insurer that benefits from the attorney's efforts to recover on the subrogation claim must contribute pro-rata to attorney fees and costs. This typically means the insurer's net recovery is reduced by the attorney's contingency percentage, which reduces the financial incentive for the insurer to vigorously pursue small subrogation claims.

The ERISA Exception: Federal Law Overrides California

Here is where things get more complicated. If your client's health insurance coverage is through an employer-sponsored ERISA plan — which covers the majority of employees with employer-provided health insurance — California's made-whole doctrine does not apply.

ERISA preempts state insurance laws. Many ERISA plan documents contain explicit subrogation provisions that:

• Require full reimbursement regardless of whether the plaintiff was made whole
• Do not permit pro-rata reduction for attorney fees (though there is significant litigation on this point post-Montanile v. Board of Trustees)
• Allow the plan to pursue equitable liens against specifically identified settlement funds

The practical consequence: an ERISA plan's subrogation claim on injury medications paid by the plan can be aggressive, and California law will not save you. The best protection is proactive pharmacy lien enrollment that takes those medications off the table entirely.

[!KEY] For clients with ERISA employer health plans, proactive pharmacy lien enrollment at intake is the only reliable defense against federal subrogation — California's made-whole doctrine cannot save medications that the ERISA plan paid for, but it has no claim at all on medications the plan never touched.

Coordination of Benefits at Settlement: Mixed Cases

Many cases involve both types of coverage — some medications were dispensed through a pharmacy lien, others were paid by health insurance before the lien was established or for conditions the attorney didn't connect to the accident at intake.

In these mixed cases:

1. Identify which medications were covered by which mechanism. The pharmacy lien provider can provide a complete list of all medications dispensed under the lien. Compare this against the insurer's Explanation of Benefits (EOB) to find any overlap or gap.

2. Handle the pharmacy lien separately. The lien is a direct obligation to the lien provider, to be negotiated and resolved independently of any subrogation claims.

3. Assess the insurer's subrogation exposure on health-insurance-paid medications. Apply made-whole analysis for fully insured plans; use plan document analysis for ERISA plans.

4. Obtain complete EOBs from the health insurer. These become part of your settlement file and are essential if the insurer later disputes the subrogation amount.

The cleaner the intake — specifically, proactive pharmacy lien enrollment from day one — the simpler this analysis becomes at settlement.

[!KEY] In mixed cases where some medications were paid by health insurance before the lien was established, pull the insurer's Explanation of Benefits (EOB) immediately — the EOB identifies which specific medications the insurer paid for, which determines exactly where the subrogation exposure begins and where the pharmacy lien record takes over.

The Practical Takeaway for Intake

The most effective subrogation risk mitigation strategy is not negotiation at settlement — it is prevention at intake. When pharmacy lien enrollment is part of your standard client intake process, you:

• Remove injury medications from the health insurance system entirely
• Eliminate subrogation exposure on those medications
• Create a cleaner settlement distribution with one fewer competing claimant
• Ensure complete, certified documentation of every medication dispensed

When clients arrive at your office with active health insurance and injury prescriptions already submitted to that insurer, you are working reactively. When you enroll them in a pharmacy lien at intake, you are working proactively — and your client benefits from the difference.

Learn how LienScripts structures pharmacy lien enrollment to simplify settlement for California PI attorneys.

Related Resources

• Early Pharmacy Lien Enrollment and Case Strength
• Settlement Allocation: Pharmacy Costs
• Medi-Cal Lien and Pharmacy Lien Overlap
• Pharmacy Lien vs. Letter of Protection
• Pharmacy Services for Personal Injury Clients: How It Works — How pharmacy liens provide $0 upfront medication access for PI patients
• What Are Medication Liens? — Glossary guide: medication lien vs. pharmacy lien explained